<?xml version="1.0" encoding="UTF-8"?>
<rootTag>
<Award>
<AwardTitle>I-Corps: Handheld fluorescence reader that provides quantitative, multiplexed detection of fluorescence signals</AwardTitle>
<AGENCY>NSF</AGENCY>
<AwardEffectiveDate>08/01/2020</AwardEffectiveDate>
<AwardExpirationDate>01/31/2021</AwardExpirationDate>
<AwardTotalIntnAmount>50000.00</AwardTotalIntnAmount>
<AwardAmount>50000</AwardAmount>
<AwardInstrument>
<Value>Standard Grant</Value>
</AwardInstrument>
<Organization>
<Code>07070000</Code>
<Directorate>
<Abbreviation>ENG</Abbreviation>
<LongName>Directorate For Engineering</LongName>
</Directorate>
<Division>
<Abbreviation>IIP</Abbreviation>
<LongName>Div Of Industrial Innovation &amp; Partnersh</LongName>
</Division>
</Organization>
<ProgramOfficer>
<SignBlockName>Andre Marshall</SignBlockName>
<PO_EMAI/>
<PO_PHON/>
</ProgramOfficer>
<AbstractNarration>The broader impact/commercial potential of this I-Corps project is an improvement in care for heart failure patients after hospitalization. Heart failure (HF) is a significant cause of medical morbidity, mortality, and high health care costs. In 2012, 1 million hospital stays were for heart failure in the United States.  Approximately twenty-five percent of recently discharged heart failure patients are readmitted within 30 days, resulting in an additional healthcare cost burden of $2.7B per year.  The proposed technology would provide an early pre-symptomatic alert of a worsening condition to enable proactive medication and/or other therapeutic care adjustments before recently discharged HF patients become symptomatic and are potentially re-hospitalized. &lt;br/&gt;&lt;br/&gt;This I-Corps project aims to improve monitoring, specifically self-monitoring in the home, for heart failure-impacted individuals. The technology allows for daily serial monitoring and tracking of NT-proBNP biomarker levels along with other analytes like Troponin, CysC, and Serum Sodium. A smartphone-connected, daily finger stick blood test would measure, track, and report circulating NT-proBNP and related cardiac biomarker levels to a healthcare provider. The proposed technology would use fluorescence detection and microfluidics along with smart-connected health features to allow healthcare providers to monitor patient status after discharge, providing an early pre-symptomatic alert of a worsening condition to enable proactive medication and/or other therapeutic care adjustments before re-hospitalization is required.&lt;br/&gt;&lt;br/&gt;This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.</AbstractNarration>
<MinAmdLetterDate>09/09/2020</MinAmdLetterDate>
<MaxAmdLetterDate>10/14/2020</MaxAmdLetterDate>
<ARRAAmount/>
<TRAN_TYPE>Grant</TRAN_TYPE>
<CFDA_NUM>47.041</CFDA_NUM>
<NSF_PAR_USE_FLAG>1</NSF_PAR_USE_FLAG>
<FUND_AGCY_CODE>4900</FUND_AGCY_CODE>
<AWDG_AGCY_CODE>4900</AWDG_AGCY_CODE>
<AwardID>2035881</AwardID>
<Investigator>
<FirstName>Jennifer</FirstName>
<LastName>Blain Christen</LastName>
<PI_MID_INIT/>
<PI_SUFX_NAME/>
<PI_FULL_NAME>Jennifer Blain Christen</PI_FULL_NAME>
<EmailAddress>Jennifer.BlainChristen@asu.edu</EmailAddress>
<PI_PHON>4809655479</PI_PHON>
<NSF_ID>000519753</NSF_ID>
<StartDate>09/09/2020</StartDate>
<EndDate/>
<RoleCode>Principal Investigator</RoleCode>
</Investigator>
<Institution>
<Name>Arizona State University</Name>
<CityName>TEMPE</CityName>
<ZipCode>852816011</ZipCode>
<PhoneNumber>4809655479</PhoneNumber>
<StreetAddress>ORSPA</StreetAddress>
<StreetAddress2><![CDATA[660 South Mill Avenue, Suite 310]]></StreetAddress2>
<CountryName>United States</CountryName>
<StateName>Arizona</StateName>
<StateCode>AZ</StateCode>
<CONGRESSDISTRICT>09</CONGRESSDISTRICT>
<CONGRESS_DISTRICT_ORG>AZ09</CONGRESS_DISTRICT_ORG>
<ORG_DUNS_NUM>943360412</ORG_DUNS_NUM>
<ORG_LGL_BUS_NAME>ARIZONA STATE UNIVERSITY</ORG_LGL_BUS_NAME>
<ORG_PRNT_DUNS_NUM>806345658</ORG_PRNT_DUNS_NUM>
</Institution>
<Performance_Institution>
<Name><![CDATA[Arizona State University]]></Name>
<CityName>Tempe</CityName>
<StateCode>AZ</StateCode>
<ZipCode>852876011</ZipCode>
<StreetAddress><![CDATA[P.O. Box 876011]]></StreetAddress>
<CountryCode>US</CountryCode>
<CountryName>United States</CountryName>
<StateName>Arizona</StateName>
<CountryFlag>1</CountryFlag>
<CONGRESSDISTRICT>09</CONGRESSDISTRICT>
<CONGRESS_DISTRICT_PERF>AZ09</CONGRESS_DISTRICT_PERF>
</Performance_Institution>
<ProgramElement>
<Code>8023</Code>
<Text>I-Corps</Text>
</ProgramElement>
<Appropriation>
<Code>0120</Code>
<Name>NSF RESEARCH &amp; RELATED ACTIVIT</Name>
<APP_SYMB_ID>040100</APP_SYMB_ID>
</Appropriation>
<FUND_OBLG>2020~50000</FUND_OBLG>
</Award>
</rootTag>
